Hinge Health
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +78.4% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 6.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation D-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 51.7x | Better than 9% |
| Forward P/E | 43.3x | Better than 9% |
| Price / Sales | 11.7x | Better than 9% |
| P/E vs own 5-yr range | 83rd pctl | Better than 23% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 79.6% | Better than 90% |
| Operating margin | -92.9% | Better than 7% |
| Net margin | -72.1% | Better than 8% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 19.6% | Better than 96% |
| 6-month return | 91.5% | Better than 99% |
| 12-month return (ex latest month) | 142.5% | Better than 97% |
| Distance below 52-week high | 16.3% | Better than 68% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.5x | Better than 40% |
| Debt to assets | 1.1% | Better than 92% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 24.7% | Better than 41% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 108.10
- Open
- 107.05
- Day range
- 103.12 - 109.18
- Avg price
- 105.72
- Volume
- 1.65M
- Turnover
- 174.41M
- Turnover ratei
- 3.26%
- Volume ratioi
- 1.00
- Amplitudei
- 5.61%
- 52-week rangei
- 30.08 - 126.40
Valuation
- P/Ei
- -19.75
- P/E (TTM)i
- 51.68
- P/Bi
- 28.71
- EPSi
- -5.36
- Book value / shi
- 3.68
- Net profit
- -435.37M
- Net assets
- 299.40M
Share structure
- Market cap
- 8.60B
- Float capi
- 5.36B
- Shares out
- 81.27M
- Float sharesi
- 50.63M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2025-05-22
16.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+17.99M net over the window
Short interest
- Shares short
- 4.98M
- % of floati
- 6.17%
- Days to coveri
- 2.39
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Hinge Health (HNGE)?
Hinge Health last traded at 105.78. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Hinge Health's market cap?
About 8.60B.
What is the P/E ratio of Hinge Health?
The trailing twelve-month P/E is 51.68, above its own 5-year average of 9.98 — toward the top of its historical range (82.89% percentile). See the Valuation tab for the full history.
Does Hinge Health pay a dividend?
Hinge Health does not currently pay a regular dividend.
Is Hinge Health a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 131.88, which implies 24.7% upside from the current price. This is not investment advice.
What is Hinge Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Hinge Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.
Hinge Health discussion 0 comments